Clinical diagnosis and management of amyotrophic lateral sclerosis (Q37944429)

25 August 2017

Clinical diagnosis and management of amyotrophic lateral sclerosis (English)

1 reference

amyotrophic lateral sclerosis

25 August 2017

0 references

0 references

1

1 reference

PubMed ID

21989247

25 August 2017

Leonard H van den Berg

series ordinal

2

object named as

Leonard H van den Berg

1 reference

25 August 2017

3

Matthew C Kiernan

1 reference

PubMed ID

21989247

25 August 2017

language of work or name

English

0 references

publication date

11 October 2011

1 reference

25 August 2017

Nature Reviews Neurology

1 reference

25 August 2017

7

1 reference

25 August 2017

11

1 reference

25 August 2017

639-649

1 reference

https://scigraph.springernature.com/pub.10.1038/nrneurol.2011.153

25 August 2017

0 references

cites work

Amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Genetic studies of amyotrophic lateral sclerosis: controversies and perspectives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The epidemiology and treatment of ALS: focus on the heterogeneity of the disease and critical appraisal of therapeutic trials

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Incidence of amyotrophic lateral sclerosis in Europe

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Epidemiology of ALS in Italy: a 10-year prospective population-based study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Amyotrophic lateral sclerosis in an urban setting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Incidence and lifetime risk of motor neuron disease in the United Kingdom: a population-based study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Ethnic variation in the incidence of ALS: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Reduced frequency of ALS in an ethnically mixed population: a population-based mortality study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Parkinsonism-dementia complex of Guam

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Atypical parkinsonism of Japan: amyotrophic lateral sclerosis-parkinsonism-dementia complex of the Kii peninsula of Japan (Muro disease): an update.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The ALS/PDC syndrome of Guam and the cycad hypothesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

What we truly know about occupation as a risk factor for ALS: A critical and systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Severely increased risk of amyotrophic lateral sclerosis among Italian professional football players

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

ALS in Italian professional soccer players: the risk is still present and could be soccer-specific.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Clinical aspects of ALS in Gulf War veterans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Amyotrophic lateral sclerosis among 1991 Gulf War veterans: evidence for a time-limited outbreak

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Smoking may be considered an established risk factor for sporadic ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Smoking and the risk of amyotrophic lateral sclerosis: a systematic review and meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Exposure to chemicals and metals and risk of amyotrophic lateral sclerosis: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

ALS motor phenotype heterogeneity, focality, and spread: deconstructing motor neuron degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Amyotrophic lateral sclerosis (ALS): a phylogenetic disease of the corticomotoneuron?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Slow saccades in bulbar-onset motor neurone disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Ocular fixation instabilities in motor neurone disease. A marker of frontal lobe dysfunction?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Cognitive impairment in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The syndromes of frontotemporal dysfunction in amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The cognitive profile of amyotrophic lateral sclerosis: A meta-analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Executive dysfunction is a negative prognostic indicator in patients with ALS without dementia.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The syndrome of cognitive impairment in amyotrophic lateral sclerosis: a population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Detecting frontotemporal dysfunction in ALS: utility of the ALS Cognitive Behavioral Screen (ALS-CBS).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Parkinsonism and motor neuron diseases: twenty-seven patients with diverse overlap syndromes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Coexistence of parkinsonism, dementia and upper motor neuron syndrome in four Czech patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Aggregation of neurodegenerative disease in ALS kindreds

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Neurodegeneration: what is it and where are we?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The natural history of primary lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Primary lateral sclerosis as a phenotypic manifestation of familial ALS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Differentiation of hereditary spastic paraparesis from primary lateral sclerosis in sporadic adult-onset upper motor neuron syndromes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Disease course and prognostic factors of progressive muscular atrophy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Corticospinal tract degeneration in the progressive muscular atrophy variant of ALS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Avoiding false positive diagnoses of motor neuron disease: lessons from the Scottish Motor Neuron Disease Register

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Correlates of outcome and response to IVIg in 88 patients with multifocal motor neuropathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Perspectives of Kennedy's disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases a

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Consensus guidelines for the design and implementation of clinical trials in ALS. World Federation of Neurology committee on Research

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Electrodiagnostic criteria for diagnosis of ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Benefit of the Awaji diagnostic algorithm for amyotrophic lateral sclerosis: a prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Are the El Escorial and Revised El Escorial criteria for ALS reproducible? A study of inter-observer agreement.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Reliability of the El Escorial diagnostic criteria for amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Clinical features of amyotrophic lateral sclerosis according to the El Escorial and Airlie House diagnostic criteria: A population-based study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Electrodiagnostic studies in amyotrophic lateral sclerosis and other motor neuron disorders

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Clinical neurophysiology of ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Transcranial magnetic stimulation identifies upper motor neuron involvement in motor neuron disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The natural history of central motor abnormalities in amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Assessment of cortical excitability using threshold tracking techniques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Novel threshold tracking techniques suggest that cortical hyperexcitability is an early feature of motor neuron disease.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Proposed criteria for familial amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Biomarkers in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Hyperintense and hypointense MRI signals of the precentral gyrus and corticospinal tract in ALS: a follow-up examination including FLAIR images

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

MRI-based functional neuroimaging in ALS: an update

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Brain metabolites in definite amyotrophic lateral sclerosis. A longitudinal proton magnetic resonance spectroscopy study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Progressive and widespread brain damage in ALS: MRI voxel-based morphometry and diffusion tensor imaging study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Frontotemporal white matter changes in amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Neuroanatomical correlates of apathy in ALS using 4 Tesla diffusion tensor MRI.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Neuroimaging of multimodal sensory stimulation in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Corpus callosum involvement is a consistent feature of amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Prognostic factors in ALS: A critical review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Natural history and clinical features of the flail arm and flail leg ALS variants

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Isolated bulbar phenotype of amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Lower serum lipid levels are related to respiratory impairment in patients with ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Patients with elevated triglyceride and cholesterol serum levels have a prolonged survival in amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Beneficial vascular risk profile is associated with amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Functional outcome measures as clinical trial endpoints in ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Effect of a multidisciplinary amyotrophic lateral sclerosis (ALS) clinic on ALS survival: a population based study, 1996-2000.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Multidisciplinary ALS care improves quality of life in patients with ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Positive effects of tertiary centres for amyotrophic lateral sclerosis on outcome and use of hospital facilities

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Good practice in the management of amyotrophic lateral sclerosis: clinical guidelines. An evidence-based review with good practice points. EALSC Working Group

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: multidisciplinary care, symptom management, and cognitive/behavioral impairment (an evidence-based review): report of the Quality Standards Subcommittee of the Am

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Practice parameter update: the care of the patient with amyotrophic lateral sclerosis: drug, nutritional, and respiratory therapies (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Toward more efficient clinical trials for amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Therapy development for ALS: lessons learned and path forward

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Management of respiratory symptoms in ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Use of Sniff nasal-inspiratory force to predict survival in amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Effects of non-invasive ventilation on survival and quality of life in patients with amyotrophic lateral sclerosis: a randomised controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The effect of noninvasive ventilation on ALS patients and their caregivers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Is a four-hour use of non-invasive ventilation enough to define compliance?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Efficacy of mechanical insufflation-exsufflation in medically stable patients with amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Botulinum toxin type A for the treatment of sialorrhoea in amyotrophic lateral sclerosis: A clinical and neurophysiological study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Botulinum toxin for the treatment of sialorrhoea in ALS: serious side effects of a transductal approach

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The use of subcutaneous glycopyrrolate in the management of sialorrhoea and facilitating the use of non-invasive ventilation in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Radiotherapy reduces sialorrhea in amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Malnutrition at the time of diagnosis is associated with a shorter disease duration in ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Energy metabolism in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Oropharyngeal dysphagia in amyotrophic lateral sclerosis: neurological and dysphagia specific rating scales

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Amyotrophic Lateral Sclerosis: Enteral Nutrition Provision—Endoscopic or Radiologic Gastrostomy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Percutaneous radiological gastrostomy: a safe and effective method of nutritional tube placement in advanced ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Noninvasive respiratory muscle aids during PEG placement in ALS patients with severe ventilatory impairment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Palliative care in amyotrophic lateral sclerosis: a review of current international guidelines and initiatives

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Patients' assessment of quality of life instruments: a randomised study of SIP, SF-36 and SEIQoL-DW in patients with amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The amyotrophic lateral sclerosis assessment questionnaire (ALSAQ-40): tests of data quality, score reliability and response rate in a survey of patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Evidence for the validity and reliability of the ALS assessment questionnaire: The ALSAQ-40

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Reduced item set for the amyotrophic lateral sclerosis assessment questionnaire: development and validation of the ALSAQ-5

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The ALSSQOL: balancing physical and nonphysical factors in assessing quality of life in ALS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Physical decline and quality of life in amyotrophic lateral sclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Cross-sectional and longitudinal correlations between disease progression and different health-related quality of life domains in persons with amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

The SEIQoL-DW for assessing quality of life in ALS: strengths and limitations.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Quality of life in ALS is maintained as physical function declines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Psychological health in patients with ALS is maintained as physical function declines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Psychological morbidity in ALS: the importance of psychological assessment beyond depression alone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Religiousness is related to quality of life in patients with ALS

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Religiousness is positively associated with quality of life of ALS caregivers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Predictors of psychological distress in carers of people with amyotrophic lateral sclerosis: a longitudinal study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

A longitudinal study on quality of life and depression in ALS patient-caregiver couples

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Existential well-being and spirituality of individuals with amyotrophic lateral sclerosis is related to psychological well-being of their caregivers.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Burden, depression, and anxiety in caregivers of people with amyotrophic lateral sclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

Some difficult decisions in ALS/MND.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEUROL.2011.153

A long-term prospective study of the natural course of sporadic adult-onset lower motor neuron syndromes.

31 March 2020

1 reference

12 December 2020

[Muro disease: amyotrophic lateral sclerosis/parkinsonism-dementia complex in Kii peninsula of Japan]

1 reference

12 December 2020

FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis

1 reference

12 December 2020

Clinical presentation and diagnosis of amyotrophic lateral sclerosis

1 reference

12 December 2020

Intracerebroventricular infusion of monoclonal antibody or its derived Fab fragment against misfolded forms of SOD1 mutant delays mortality in a mouse model of ALS

1 reference

12 December 2020

Amyotrophic Lateral Sclerosis Mimic Syndromes

1 reference

12 December 2020

10.1038/NRNEUROL.2011.153

Identifiers

DOI

1 reference

25 August 2017

1 reference

PubMed ID

21989247